RESUMO
Cuando sufre despersonalización, el individuo se queja espontáneamente de la vivencia de que su propia actividad mental, su cuerpo, su entorno o todos ellos, están cualitativamente transformados, de manera que se han vuelto irreales, lejanos o mecánicos. Este fenómeno está asociado frecuentemente con otros trastornos mentales, como en el caso que presentamos. Entre los muchos fármacos estudiados, ninguno ha mostrado ser el tratamiento de elección. Entre aquellos que han obtenido mejores resultados están los antagonistas de los receptores de los opioides, la combinación de inhibidores selectivos de la recaptación de la serotonina con lamotrigina, y la clorimipramina. Presentamos un caso resistente que respondió a lamotrigina (AU)
The individuals with depersonalizattion disorder suffer from a painful feeling that their body and mental experiences or the experiences of the environment seem become unreal, distant or mechanical. This phenomenon is often associated with other mental disorders, as in the case presented. Among the many psychoactive drugs studied, none of them has been shown to be the treatment of choice. Among those with which the best results are obtained are opioid receptor antagonists, the combination of selective serotonin reuptake inhibitors with lamotrigine and clorimipramine. We are presenting a resistant case that responded to lamotrigine(AU)
Assuntos
Humanos , Feminino , Adulto , Despersonalização/tratamento farmacológico , Inibidores Seletivos de Recaptação de Serotonina/farmacocinética , Resistência a Medicamentos , Comorbidade , Transtorno da Personalidade Borderline/diagnóstico , Transtorno Obsessivo-Compulsivo/diagnósticoRESUMO
The individuals with depersonalizattion disorder suffer from a painful feeling that their body and mental experiences or the experiences of the environment seem become unreal, distant or mechanical. This phenomenon is often associated with other mental disorders, as in the case presented. Among the many psychoactive drugs studied, none of them has been shown to be the treatment of choice. Among those with which the best results are obtained are opioid receptor antagonists, the combination of selective serotonin reuptake inhibitors with lamotrigine and clorimipramine. We are presenting a resistant case that responded to lamotrigine.
